US Stock MarketDetailed Quotes

Entera Bio (ENTX)

Watchlist
  • 1.200
  • +0.020+1.69%
Close Apr 16 16:00 ET
  • 1.200
  • 0.0000.00%
Post 20:01 ET
65.34MMarket Cap-4.80P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Entera Bio (ENTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-76.80%42K
0
0
0
42K
181K
82K
42K
57K
0
Operating revenue
-76.80%42K
--0
--0
--0
--42K
--181K
--82K
--42K
--57K
--0
Cost of revenue
-75.58%42K
0
0
0
42K
172K
82K
42K
48K
0
Gross profit
0
0
0
0
0
9K
0
0
9K
0
Operating expense
20.17%11.53M
30.17%3.04M
7.78%3.26M
22.72%2.67M
24.30%2.56M
7.91%9.59M
19.05%2.34M
26.61%3.02M
-6.70%2.17M
-6.78%2.06M
Selling and administrative expenses
8.44%5.53M
16.55%1.32M
4.47%1.61M
5.51%1.15M
8.52%1.44M
15.01%5.1M
16.75%1.14M
50.19%1.54M
-4.14%1.09M
2.55%1.33M
-General and administrative expense
8.44%5.53M
16.55%1.32M
4.47%1.61M
5.51%1.15M
8.52%1.44M
15.01%5.1M
16.75%1.14M
50.19%1.54M
-4.14%1.09M
2.55%1.33M
Research and development costs
33.45%6M
43.05%1.72M
11.24%1.64M
39.96%1.52M
52.79%1.12M
-0.24%4.5M
20.10%1.2M
7.81%1.48M
-10.17%1.09M
-21.05%735K
Operating profit
-20.28%-11.53M
-30.17%-3.04M
-7.78%-3.26M
-23.23%-2.67M
-24.30%-2.56M
-7.81%-9.59M
-19.05%-2.34M
-26.61%-3.02M
7.08%-2.17M
6.78%-2.06M
Net non-operating interest income expense
55.17%90K
471.43%26K
56K
-40.00%12K
-108.89%-4K
87.10%58K
78.13%-7K
0
300.00%20K
104.55%45K
Non-operating interest income
----
----
----
-40.00%12K
----
----
----
----
--20K
104.55%45K
Total other finance cost
-55.17%-90K
-471.43%-26K
---56K
----
108.89%4K
-87.10%-58K
-78.13%7K
----
-300.00%-20K
---45K
Other net income (expense)
Income before tax
-20.07%-11.44M
-28.67%-3.02M
-5.93%-3.2M
-23.82%-2.66M
-27.27%-2.57M
-7.53%-9.53M
-17.49%-2.34M
-28.55%-3.02M
7.74%-2.15M
7.90%-2.02M
Income tax
0
-51.72%14K
14K
0
Net income
-19.89%-11.44M
-27.91%-3.02M
-5.93%-3.2M
-23.82%-2.66M
-27.27%-2.57M
-7.33%-9.54M
-18.20%-2.36M
-26.99%-3.02M
7.74%-2.15M
7.90%-2.02M
Net income continuous Operations
-19.89%-11.44M
-27.91%-3.02M
-5.93%-3.2M
-23.82%-2.66M
-27.27%-2.57M
-7.33%-9.54M
-18.20%-2.36M
-26.99%-3.02M
7.74%-2.15M
7.90%-2.02M
Minority interest income
Net income attributable to the parent company
-19.89%-11.44M
-27.91%-3.02M
-5.93%-3.2M
-23.82%-2.66M
-27.27%-2.57M
-7.33%-9.54M
-18.20%-2.36M
-26.99%-3.02M
7.74%-2.15M
7.90%-2.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-19.89%-11.44M
-27.91%-3.02M
-5.93%-3.2M
-23.82%-2.66M
-27.27%-2.57M
-7.33%-9.54M
-18.20%-2.36M
-26.99%-3.02M
7.74%-2.15M
7.90%-2.02M
Basic earnings per share
0.00%-0.25
-16.67%-0.07
12.50%-0.07
0.00%-0.06
-20.00%-0.06
19.35%-0.25
14.29%-0.06
0.00%-0.08
25.00%-0.06
37.50%-0.05
Diluted earnings per share
0.00%-0.25
-16.67%-0.07
12.50%-0.07
0.00%-0.06
-20.00%-0.06
19.35%-0.25
14.29%-0.06
0.00%-0.08
25.00%-0.06
37.50%-0.05
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -76.80%42K00042K181K82K42K57K0
Operating revenue -76.80%42K--0--0--0--42K--181K--82K--42K--57K--0
Cost of revenue -75.58%42K00042K172K82K42K48K0
Gross profit 000009K009K0
Operating expense 20.17%11.53M30.17%3.04M7.78%3.26M22.72%2.67M24.30%2.56M7.91%9.59M19.05%2.34M26.61%3.02M-6.70%2.17M-6.78%2.06M
Selling and administrative expenses 8.44%5.53M16.55%1.32M4.47%1.61M5.51%1.15M8.52%1.44M15.01%5.1M16.75%1.14M50.19%1.54M-4.14%1.09M2.55%1.33M
-General and administrative expense 8.44%5.53M16.55%1.32M4.47%1.61M5.51%1.15M8.52%1.44M15.01%5.1M16.75%1.14M50.19%1.54M-4.14%1.09M2.55%1.33M
Research and development costs 33.45%6M43.05%1.72M11.24%1.64M39.96%1.52M52.79%1.12M-0.24%4.5M20.10%1.2M7.81%1.48M-10.17%1.09M-21.05%735K
Operating profit -20.28%-11.53M-30.17%-3.04M-7.78%-3.26M-23.23%-2.67M-24.30%-2.56M-7.81%-9.59M-19.05%-2.34M-26.61%-3.02M7.08%-2.17M6.78%-2.06M
Net non-operating interest income expense 55.17%90K471.43%26K56K-40.00%12K-108.89%-4K87.10%58K78.13%-7K0300.00%20K104.55%45K
Non-operating interest income -------------40.00%12K------------------20K104.55%45K
Total other finance cost -55.17%-90K-471.43%-26K---56K----108.89%4K-87.10%-58K-78.13%7K-----300.00%-20K---45K
Other net income (expense)
Income before tax -20.07%-11.44M-28.67%-3.02M-5.93%-3.2M-23.82%-2.66M-27.27%-2.57M-7.53%-9.53M-17.49%-2.34M-28.55%-3.02M7.74%-2.15M7.90%-2.02M
Income tax 0-51.72%14K14K0
Net income -19.89%-11.44M-27.91%-3.02M-5.93%-3.2M-23.82%-2.66M-27.27%-2.57M-7.33%-9.54M-18.20%-2.36M-26.99%-3.02M7.74%-2.15M7.90%-2.02M
Net income continuous Operations -19.89%-11.44M-27.91%-3.02M-5.93%-3.2M-23.82%-2.66M-27.27%-2.57M-7.33%-9.54M-18.20%-2.36M-26.99%-3.02M7.74%-2.15M7.90%-2.02M
Minority interest income
Net income attributable to the parent company -19.89%-11.44M-27.91%-3.02M-5.93%-3.2M-23.82%-2.66M-27.27%-2.57M-7.33%-9.54M-18.20%-2.36M-26.99%-3.02M7.74%-2.15M7.90%-2.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -19.89%-11.44M-27.91%-3.02M-5.93%-3.2M-23.82%-2.66M-27.27%-2.57M-7.33%-9.54M-18.20%-2.36M-26.99%-3.02M7.74%-2.15M7.90%-2.02M
Basic earnings per share 0.00%-0.25-16.67%-0.0712.50%-0.070.00%-0.06-20.00%-0.0619.35%-0.2514.29%-0.060.00%-0.0825.00%-0.0637.50%-0.05
Diluted earnings per share 0.00%-0.25-16.67%-0.0712.50%-0.070.00%-0.06-20.00%-0.0619.35%-0.2514.29%-0.060.00%-0.0825.00%-0.0637.50%-0.05
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -